OCX,AXON Stock Price and Quote

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change -0.02
Percentage change -0.95	%

Peers: EXAS CDNA GH FLGT ILMN MYGN BNTX RCKT CRSP TXG

| Held by: VTI VXF IWC DFAC

Index	-	P/E	-	EPS (ttm)	-4.43	Insider Own	21.63%	Shs Outstand	13.37M	Perf Week	-5.88%
Market Cap	35.01M	Forward P/E	-	EPS next Y	-1.54	Insider Trans	69.09%	Shs Float	13.19M	Perf Month	-6.31%
Income	-43.61M	PEG	-	EPS next Q	-0.40	Inst Own	51.28%	Short Float	2.42%	Perf Quarter	-33.12%
Sales	0.71M	P/S	49.31	EPS this Y	26.93%	Inst Trans	1.34%	Short Ratio	4.02	Perf Half Y	-36.97%
Book/sh	0.73	P/B	2.86	EPS next Y	43.92%	ROA	-56.84%	Short Interest	0.32M	Perf Year	-37.91%
Cash/sh	0.20	P/C	10.42	EPS next 5Y	-	ROE	-165.32%	52W Range	1.97 - 3.57	Perf YTD	-12.61%
Dividend Est.	-	P/FCF	-	EPS past 5Y	14.72%	ROI	-351.16%	52W High	-41.72%	Beta	0.92
Dividend TTM	-	Quick Ratio	0.47	Sales past 5Y	20.31%	Gross Margin	-166.22%	52W Low	5.58%	ATR (14)	0.18
Dividend Ex-Date	-	Current Ratio	0.49	EPS Y/Y TTM	66.17%	Oper. Margin	-3227.36%	RSI (14)	37.87	Volatility	8.05% 8.29%
Employees	46	Debt/Eq	0.41	Sales Y/Y TTM	-	Profit Margin	-6150.92%	Recom	2.33	Target Price	4.12
Option/Short	No / Yes	LT Debt/Eq	0.28	EPS Q/Q	-21.47%	Payout	-	Rel Volume	0.35	Prev Close	2.10
Sales Surprise	-35.50%	EPS Surprise	7.99%	Sales Q/Q	-73.19%	Earnings	Nov 12 AMC	Avg Volume	79.43K	Price	2.08
SMA20	-6.05%	SMA50	-14.64%	SMA200	-26.23%	Trades		Volume	28,120	Change	-0.95%

Date	Action	Analyst	Rating Change	Price Target Change
May-24-22	Downgrade	Stephens	Overweight → Equal-Weight
Mar-14-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jan-07-22	Initiated	Stephens	Overweight	$3.10
Jan-06-22	Resumed	Piper Sandler	Overweight	$3.10
Mar-17-21	Resumed	Needham	Buy	$8
Jan-07-21	Upgrade	The Benchmark Company	Speculative Buy → Buy	$6
Dec-16-20	Upgrade	Piper Sandler	Neutral → Overweight	$2 → $4
Nov-30-20	Initiated	BTIG Research	Buy	$5
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$5
Jul-30-20	Reiterated	The Benchmark Company	Speculative Buy	$7 → $6
Jul-01-20	Downgrade	Piper Sandler	Overweight → Neutral
Jun-30-20	Downgrade	Chardan Capital Markets	Buy → Neutral	$2
Jun-02-20	Initiated	Needham	Buy	$4
Feb-13-19	Initiated	Piper Jaffray	Overweight	$6
Jan-29-19	Upgrade	Janney	Neutral → Buy
Dec-19-18	Resumed	Lake Street	Buy

Show Previous Ratings

Jan-08-25 08:30AM	Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer (GlobeNewswire)
Jan-06-25 04:05PM	Oncocyte Expands Market Opportunity for VitaGraft Kidney (GlobeNewswire)
Dec-09-24 04:05PM	Oncocyte to Participate in J.P. Morgan Week and Host Investor Meetings (GlobeNewswire)
Dec-04-24 04:15PM	Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study (GlobeNewswire)
Dec-02-24 04:05PM	Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms (GlobeNewswire)
02:21AM	Loading…
Nov-13-24 02:21AM	OncoCyte Corp (OCX) Q3 2024 Earnings Call Highlights: Progress in Transplant Testing and ... (GuruFocus.com)
Nov-12-24 04:05PM	Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025 (GlobeNewswire)
Nov-06-24 04:45PM	Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12 (GlobeNewswire)
Oct-16-24 04:15PM	Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles (GlobeNewswire)
Oct-08-24 08:30AM	Oncocyte's DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial (GlobeNewswire)
Oct-04-24 06:28AM	OncoCyte Secures Funding Through Private Share Sale (TipRanks)
Oct-02-24 06:41PM	Oncocyte Signs Leading Transplant Centers in US and Germany (GlobeNewswire)
06:35PM	Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
Aug-20-24 09:00AM	PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology (GlobeNewswire)
Aug-12-24 04:10PM	Oncocyte's VitaGraft Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study (GlobeNewswire) -5.13%
04:05PM	Loading…
Aug-08-24 04:05PM	Oncocyte Announces Successful GraftAssure Beta Launch and Q2 2024 Results (GlobeNewswire)
Aug-05-24 04:05PM	Oncocyte Announces August Investor Conferences Participation (GlobeNewswire) +6.27%
Aug-01-24 04:05PM	Oncocyte to Announce Second Quarter 2024 Financial Results on August 8 (GlobeNewswire) -5.14%
Jul-11-24 08:00AM	MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in 'Take Advantage of the Moment' Episode (GlobeNewswire)
Jun-24-24 12:41PM	Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move (GlobeNewswire) -6.36%
Jun-17-24 04:05PM	Oncocyte Appoints Andrea James as Chief Financial Officer (GlobeNewswire)
Jun-05-24 07:00AM	OncoCyte's Innovative Approach: Potential in Precision Diagnostics (News Direct)
Jun-03-24 02:13PM	Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study (GlobeNewswire)
May-30-24 04:47PM	Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine (GlobeNewswire)
May-15-24 08:55PM	OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:05PM	Oncocyte Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-13-24 08:00AM	Oncocyte to Announce First Quarter 2024 Financial Results (GlobeNewswire)
May-07-24 09:19AM	PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace (GlobeNewswire)
Apr-12-24 10:52AM	OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -8.60%
06:00AM	Oncocyte Reports Full Year 2023 Financial Results (GlobeNewswire)
09:46PM	Loading…
Apr-11-24 09:46PM	Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
05:30PM	Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay (GlobeNewswire)
Apr-09-24 04:05PM	Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Jan-16-24 08:00AM	Oncocyte to Present at the Sequire Investor Summit in Puerto Rico (GlobeNewswire)
Dec-06-23 08:00AM	Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays (GlobeNewswire)
Nov-09-23 08:27AM	OncoCyte Corp (OCX) Reports Q3 2023 Financial Results with Key Product Launches on the Horizon (GuruFocus.com) +29.71%
07:00AM	Oncocyte Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-03-23 08:30AM	Oncocyte to Announce Third Quarter 2023 Financial Results (GlobeNewswire) +8.09%
Sep-18-23 08:00AM	Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier (ACCESSWIRE) +5.49%
Sep-06-23 08:00AM	Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference (ACCESSWIRE)
Aug-28-23 08:30AM	Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage (ACCESSWIRE)
Aug-10-23 07:00AM	Oncocyte Reports Second Quarter 2023 Financial Results (ACCESSWIRE)
Aug-09-23 08:00AM	Oncocyte Regains Compliance With Nasdaq Listing Requirements (ACCESSWIRE)
Aug-08-23 08:30AM	Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference (ACCESSWIRE) -5.29%
Aug-03-23 08:00AM	Oncocyte To Announce Second Quarter 2023 Financial Results (ACCESSWIRE)
Jul-25-23 09:08AM	VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients (GlobeNewswire)
Jul-24-23 01:35PM	Oncocyte Announces 1-For-20 Reverse Stock Split (GlobeNewswire) -9.57%
Jun-27-23 08:30AM	Oncocyte Begins Manufacturing Transplant Blood Test (GlobeNewswire)
Jun-01-23 04:15PM	Oncocyte Corporation to Present at the LD Micro Invitational XIII (Newsfile) +6.55%
May-11-23 08:00AM	Oncocyte Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-27-23 04:59PM	Oncocyte To Announce First Quarter 2023 Financial Results (GlobeNewswire) +9.86%
Apr-18-23 08:45AM	Oncocyte Presents New Data at AACR (GlobeNewswire)
Apr-12-23 04:15PM	Oncocyte Announces Reduction in Force (GlobeNewswire) -5.08%
Apr-07-23 08:24AM	Oncocyte Announces Publication of DetermaIO Results from AtezoTRIBE Study in Metastatic Colorectal Cancer (GlobeNewswire)
Apr-03-23 08:00AM	Oncocyte Pricing of $13.86 Million Public Offering of Common Stock (GlobeNewswire) -10.41%
Mar-31-23 05:00PM	Oncocyte Reports Preliminary Fourth Quarter and Full Year 2022 Financial Results and Plans to File Form 12b-25 to Extend Filing Date of Its Form 10-K (GlobeNewswire) +26.57%
Mar-29-23 04:01PM	Oncocyte Announces Date Change for Fourth Quarter and Full Year 2022 Earnings Call (GlobeNewswire) +5.52% -8.50%
Mar-15-23 04:01PM	Oncocyte to Announce Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) -20.00% +51.50%
Mar-02-23 09:00AM	Oncocyte Appoints Joshua Riggs as President and Chief Executive Officer (GlobeNewswire)
Feb-22-23 08:00AM	Oncocyte Completes Razor Genomics Transaction (GlobeNewswire)
Dec-16-22 08:19AM	Oncocyte cuts 40% of staff (MarketWatch) -21.95%
08:00AM	Oncocyte Announces Initiatives to Focus Corporate Strategy (GlobeNewswire)
Nov-30-22 06:05PM	Oncocyte Announces the Appointment of Louis E. Silverman as a Member of Its Board of Directors (GlobeNewswire)
06:00PM	Oncocyte Announces Executive Leadership Changes (GlobeNewswire)
Nov-10-22 04:30PM	Oncocyte Reports Third Quarter 2022 Financial Results (GlobeNewswire) -21.72%
Oct-27-22 04:01PM	Oncocyte to Announce Third Quarter 2022 Financial Results (GlobeNewswire) -13.50%
Oct-06-22 08:00AM	DetermaIO Clinical Test to be used in SWOG Cancer Research Network Biomarker Study for Breast Cancer (GlobeNewswire)
Sep-07-22 08:00AM	Oncocyte Announces Unanimous Recommendation from the Advisory Panel for Clinical Diagnostic Laboratory Tests on DetermaRx to CMS (GlobeNewswire)
Aug-31-22 04:01PM	Oncocyte to Participate at the Lake Street 6th Annual Best Ideas Growth Conference (GlobeNewswire)
Aug-30-22 04:27PM	Oncocyte Announces Five-Year VA Contract for DetermaRx (GlobeNewswire) -6.93%
Aug-24-22 08:00AM	Oncocyte Announces Publication of the Validation of DetermaIO in Predicting Immune Therapy Response in Metastatic Bladder Cancer (GlobeNewswire)
Aug-10-22 04:05PM	Oncocyte Reports Second Quarter 2022 Financial Results (GlobeNewswire) +10.57%
Aug-03-22 04:01PM	Oncocyte to Participate at Upcoming Investor Conferences (GlobeNewswire) +13.60%
Aug-01-22 11:33AM	The past year for OncoCyte (NASDAQ:OCX) investors has not been profitable (Simply Wall St.)
05:00AM	Oncocyte Announces the Appointment of John Peter Gutfreund as Independent Member of Its Board of Directors Effective July 28, 2022 (GlobeNewswire)
Jul-27-22 04:01PM	Oncocyte to Announce Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-13-22 08:00AM	Oncocyte Announces Market Entry and Early Adopter Program for Transplant Rejection Monitoring Business (GlobeNewswire) +5.75%
Jul-06-22 08:00AM	Oncocyte Presents DetermaIO Data in Podium Presentation at ESMO World Congress on Gastrointestinal Cancer 2022 (GlobeNewswire)
Jun-22-22 08:00AM	Oncocyte Hosting Key Opinion Webinar on the Role of DetermaIO and the Tumor Microenvironment in Clinical Practice (GlobeNewswire)
Jun-15-22 07:15AM	How Much Of OncoCyte Corporation (NASDAQ:OCX) Do Insiders Own? (Simply Wall St.)
May-26-22 05:00PM	Oncocyte Presents DetermaIO Data at ASCO 2022 Supporting the Tests Potential to Expand the Clinical Use of Immunotherapy (GlobeNewswire)
May-11-22 04:05PM	Oncocyte Reports First Quarter 2022 Financial Results (GlobeNewswire)
May-05-22 08:00AM	Oncocyte Completes Validation of TheraSure Transplant Monitor Test (GlobeNewswire)
Apr-28-22 04:01PM	Oncocyte to Announce First Quarter 2022 Financial Results (GlobeNewswire)
Apr-27-22 04:30PM	Oncocyte to Present New Data at ASCO 2022 Underpinning Pan-Cancer Clinical Utility of DetermaIO (GlobeNewswire)
Apr-22-22 09:26AM	A number of insiders bought OncoCyte Corporation (NASDAQ:OCX) stock last year, which is great news for shareholders (Simply Wall St.)
Apr-13-22 10:01PM	Oncocyte Corporation Announces Pricing of Public Offering of Common Stock and Warrants (GlobeNewswire)
05:12PM	Oncocyte Corporation Announces Proposed Public Offering of Common Stock and Warrants (GlobeNewswire)
05:10PM	Oncocyte Corporation Announces Pricing of Registered Direct Offering of 11,765 Shares of Series A Convertible Preferred Stock (GlobeNewswire)
Apr-11-22 08:00AM	Oncocyte Presents Confirmatory Data for DetermaIO at the American Association for Cancer Research Annual Meeting 2022 (GlobeNewswire)
Mar-28-22 08:00AM	Oncocyte to Present New Data Confirming Association of IO Score with Response to Immunotherapy Treatment for Bladder Cancer at the American Association for Cancer Research Annual Meeting 2022 (GlobeNewswire)
Mar-10-22 04:05PM	Oncocyte Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update (GlobeNewswire) +7.69% -7.86%
Mar-01-22 04:05PM	Oncocyte to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday March 10 (GlobeNewswire)
Feb-21-22 07:26AM	Shareholders in OncoCyte (NASDAQ:OCX) have lost 78%, as stock drops 12% this past week (Simply Wall St.)
Feb-10-22 08:00AM	Oncocyte to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-18-22 04:05PM	Oncocyte Announces Development and Co-Marketing Agreement with Thermo Fisher Scientific to Expand Access to Precision Oncology (GlobeNewswire) +15.87% -24.20%
Jan-06-22 09:43AM	What Type Of Shareholders Make Up OncoCyte Corporation's (NASDAQ:OCX) Share Registry? (Simply Wall St.)
Jan-04-22 08:00AM	Oncocyte Announces Peer-Reviewed Publication in Cancers Showing Utility of DetermaCNI Blood-Only Monitoring Test to Detect Recurrence Following Surgery in Epithelial Ovarian Cancer (GlobeNewswire)
Dec-09-21 06:00PM	Spotlight Poster Presentation at San Antonio Breast Cancer Symposium SABCS 2021 Shows Oncocytes DetermaIO Clinical Test Predicts Response to Immunotherapy in Triple Negative Breast Cancer (GlobeNewswire) -9.81% -6.28%
Dec-08-21 08:00AM	Oncocyte and Burning Rock Complete Technology Transfer Part Two and Prepare for Scaled Distribution of DetermaRx in China (GlobeNewswire) +10.42%

OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SMITH PATRICK W	10% Owner	Jan 14 '25	Buy	2.15	10,386	22,323	1,789,958	Jan 15 05:00 PM
SMITH PATRICK W	10% Owner	Jan 13 '25	Buy	2.08	5,669	11,792	1,779,572	Jan 15 05:00 PM
SMITH PATRICK W	10% Owner	Dec 26 '24	Buy	2.13	90,219	192,166	1,773,903	Dec 27 09:49 PM
Arno Andrew	Director	Dec 26 '24	Buy	2.11	12,500	26,350	81,554	Dec 26 06:17 PM
James Andrea S.	Chief Financial Officer	Dec 05 '24	Buy	2.29	20,000	45,800	53,670	Dec 09 08:00 AM
James Andrea S.	Chief Financial Officer	Oct 02 '24	Buy	2.97	33,670	100,000	33,670	Oct 04 07:40 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Oct 02 '24	Buy	2.95	1,315,339	3,877,619	6,244,405	Oct 04 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 11 '24	Buy	2.92	2,420,000	7,057,688	4,929,066	Apr 15 07:21 PM
Riggs Josh	CEO and President	Apr 11 '24	Buy	2.95	3,390	10,000	3,505	Apr 15 06:04 AM
Arno Andrew	Director	Apr 11 '24	Buy	2.95	33,898	99,999	69,054	Apr 15 06:02 AM

Dollar change +8.05
Percentage change 1.37	%

AXON Axon Enterprise Inc daily Stock Chart

Peers: KTOS SWBI VSTO DGLY NPK SPWH ADI DLTH

| Held by: VTI VOO VO QQQ SPY IVV VUG VOT ITA IWP

Index	NDX, S&P 500	P/E	153.79	EPS (ttm)	3.86	Insider Own	4.94%	Shs Outstand	76.08M	Perf Week	4.19%
Market Cap	45.29B	Forward P/E	94.59	EPS next Y	6.28	Insider Trans	-14.81%	Shs Float	72.49M	Perf Month	-8.53%
Income	298.31M	PEG	7.29	EPS next Q	1.40	Inst Own	80.67%	Short Float	3.54%	Perf Quarter	36.89%
Sales	1.94B	P/S	23.33	EPS this Y	24.31%	Inst Trans	0.95%	Short Ratio	2.84	Perf Half Y	94.29%
Book/sh	27.60	P/B	21.52	EPS next Y	22.01%	ROA	8.22%	Short Interest	2.57M	Perf Year	137.07%
Cash/sh	15.22	P/C	39.02	EPS next 5Y	21.10%	ROE	16.48%	52W Range	247.04 - 698.67	Perf YTD	-0.07%
Dividend Est.	-	P/FCF	205.67	EPS past 5Y	35.57%	ROI	10.58%	52W High	-15.00%	Beta	1.04
Dividend TTM	-	Quick Ratio	2.63	Sales past 5Y	31.07%	Gross Margin	59.67%	52W Low	140.40%	ATR (14)	20.45
Dividend Ex-Date	-	Current Ratio	2.96	EPS Y/Y TTM	98.63%	Oper. Margin	6.04%	RSI (14)	49.34	Volatility	2.31% 3.34%
Employees	3330	Debt/Eq	0.34	Sales Y/Y TTM	32.29%	Profit Margin	15.37%	Recom	1.28	Target Price	626.43
Option/Short	Yes / Yes	LT Debt/Eq	0.34	EPS Q/Q	9.77%	Payout	0.00%	Rel Volume	0.59	Prev Close	585.84
Sales Surprise	3.60%	EPS Surprise	21.01%	Sales Q/Q	31.59%	Earnings	Nov 07 AMC	Avg Volume	904.72K	Price	593.89
SMA20	-0.45%	SMA50	-2.33%	SMA200	45.85%	Trades		Volume	533,530	Change	1.37%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-25	Initiated	TD Cowen	Buy	$700
Dec-03-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$500 → $700
Sep-12-24	Reiterated	JMP Securities	Mkt Outperform	$375 → $430
Jul-17-24	Initiated	Jefferies	Buy	$385
Jul-17-24	Initiated	BofA Securities	Buy	$380
Apr-10-24	Reiterated	Needham	Buy	$315 → $400
Mar-13-24	Initiated	Argus	Buy	$380
Aug-22-23	Initiated	Morgan Stanley	Equal-Weight	$230
Jul-05-23	Resumed	JP Morgan	Overweight	$236
May-11-23	Upgrade	JP Morgan	Neutral → Overweight	$236
Mar-08-23	Initiated	Goldman	Buy	$263
Mar-02-23	Downgrade	JP Morgan	Overweight → Neutral	$224
Feb-17-23	Downgrade	Raymond James	Strong Buy → Outperform	$223
Sep-15-22	Initiated	Barclays	Overweight	$147
May-23-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$120
May-10-22	Initiated	Credit Suisse	Outperform	$169
Feb-25-22	Upgrade	JP Morgan	Neutral → Overweight	$222 → $192
Dec-14-21	Resumed	JMP Securities	Mkt Outperform	$195
Nov-16-21	Upgrade	Craig Hallum	Hold → Buy	$232
May-19-21	Upgrade	Raymond James	Mkt Perform → Strong Buy	$150

Show Previous Ratings

Jan-17-25 06:00PM	Why Axon Enterprise (AXON) Outpaced the Stock Market Today (Zacks)
09:44AM	Strong Results Lifted Axon Enterprise (AXON) in Q4 (Insider Monkey)
Jan-13-25 09:20AM	Heres Why Infuse Asset Management is Looking to Trim Axon Enterprise (AXON) (Insider Monkey)
Jan-11-25 05:22PM	Axons Global Expansion Could Spark Its Next Big Rally (TipRanks)
10:00AM	The Top Stock Funds of 2024 (The Wall Street Journal)
06:00PM	Loading…
Jan-10-25 06:00PM	Axon Enterprise (AXON) Stock Moves -1.27%: What You Should Know (Zacks)
01:15PM	Why Axon Stock Jumped 130% in 2024 (Motley Fool)
Jan-09-25 11:55AM	Why Axon Could Be the Best Stock to Buy in January (Motley Fool)
09:00AM	Is Most-Watched Stock Axon Enterprise, Inc (AXON) Worth Betting on Now? (Zacks)
Jan-08-25 04:42PM	Why Does Jim Cramer Think Axon Enterprise, Inc. (AXON) Overlooked Stock Deserves More Attention? (Insider Monkey)
Jan-06-25 04:34PM	S&P 500 Gains and Losses Today: Chip Stocks Jump as Foxconn Spotlights AI Demand (Investopedia) -5.05%
Jan-05-25 03:45AM	1 Potential Stock-Split AI Stock Up 1,780% in 20 Years to Buy in 2025, According to Wall Street (Motley Fool)
Jan-03-25 06:00PM	Axon Enterprise (AXON) Rises But Trails Market: What Investors Should Know (Zacks) -5.05%
Dec-27-24 03:02AM	Meet the Newest Stock in the Nasdaq-100. It's Soared 110,600% Since Its IPO and It's Still a Buy Heading Into 2025, According to Wall Street. (Motley Fool)
Dec-26-24 03:39PM	In IBD Big Cap 20, Earnings Prospects Look Bright For These Top Tech Names (Investor's Business Daily)
09:00AM	Loading…
Dec-25-24 09:00AM	Axon Enterprise, Inc (AXON) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Dec-24-24 09:30AM	Why Axon Enterprise (AXON) is a Top Stock for the Long-Term (Zacks)
Dec-23-24 11:07AM	Palantir, MicroStrategy, Axon Stocks Fall on Their First Day in Nasdaq 100 (Investopedia)
07:30AM	5 Things to Know Before the Stock Market Opens (Investopedia)
Dec-20-24 12:56PM	What the Last Triple-Witching of 2024 Could Mean For Your Stocks (Investopedia)
Dec-19-24 02:06PM	Axon Enterprise (AXON) Sees Stock Surge with Strong Q3 Results and SaaS Diversification (Insider Monkey)
04:05AM	Meet the Monster Stock That Continues to Crush the Market (Motley Fool)
Dec-17-24 05:55PM	What the company behind Taser expects under Trump's second term (Yahoo Finance Video)
10:55AM	Palantirs high valuation paints a stark picture of the S&P 500s priciest picks (MarketWatch)
09:30AM	Wall Street Analysts Think Axon (AXON) Is a Good Investment: Is It? (Zacks)
09:13AM	These Drone Stocks May Be On The Case In New Jersey (Investor's Business Daily)
06:37AM	Bitcoin Price Nears $108,000. Crypto Bulls See It Jumping This High. (Barrons.com)
Dec-16-24 04:53PM	Could Lockheed, Northrop, and RTX gain from US drone sightings? (Yahoo Finance Video)
04:04PM	Palantir Falls Despite Nasdaq 100 News, MicroStrategy Rises; Super Micro Gets The Axe (Investor's Business Daily)
02:13PM	Why Axon Enterprise (AXON) Is Among the Best Aerospace and Defense Stocks to Buy Right Now? (Insider Monkey)
11:28AM	Loading…
11:28AM	Palantir, Axon Tumble Despite Nasdaq 100 News, MicroStrategy Rises; Super Micro Get The Axe (Investor's Business Daily)
10:28AM	Palantir Stock Retreats, MicroStrategy Rises on News of Nasdaq 100 Addition (Investopedia)
10:28AM	Bitcoin Buyer MicroStrategy Leads Trio of Nasdaq 100 Index Debuts (Investopedia)
10:06AM	Palantir, MicroStrategy, Axon Join Nasdaq 100; Moderna, Super Micro Get The Axe (Investor's Business Daily)
09:25AM	MicroStrategy, Palantir, Axon to join the Nasdaq 100 next week (Yahoo Finance Video)
08:25AM	Super Micro Computer Stock Slumps on Nasdaq 100 Removal, Rumored Capital Raise (Investopedia)
07:56AM	5 Things to Know Before the Stock Market Opens (Investopedia)
Dec-15-24 10:03PM	Watch These Palantir Price Levels After Stock's Nasdaq 100 Inclusion (Investopedia)
Dec-14-24 06:19AM	These 10 most-loved S&P 500 stocks could see as much as 50% upside in 2025 (MarketWatch)
Dec-13-24 09:09PM	Saylors MicroStrategy Scores Again With Nasdaq 100 Addition (Bloomberg)
08:20PM	Palantir, MicroStrategy, and Axon Enterprise To Join Nasdaq 100 (Investopedia)
08:00PM	Annual Changes to the Nasdaq-100 Index (GlobeNewswire)
07:54PM	Palantir, MicroStrategy Likely To Join Nasdaq 100; Will Moderna, Super Micro Get The Axe? (Investor's Business Daily)
Dec-12-24 01:59PM	Stock Market Today: Sellers Take Profits But Online Gambling Stock Clears Base; Arm Works On New Base (Live Coverage) (Investor's Business Daily)
09:00AM	Axon Enterprise, Inc (AXON) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:17AM	Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies (MarketWatch)
Dec-11-24 09:45AM	Breakout Watch: Axon Peer In Buy Range After Flashing This Telltale Signal (Investor's Business Daily)
Dec-10-24 04:00PM	Axon Peer In Buy Range After Flashing This Telltale Signal (Investor's Business Daily)
Dec-09-24 05:31PM	S&P 500 Gains and Losses Today: Hershey Stock Simmers as Mondelez Weighs Takeover (Investopedia) -6.56%
09:30AM	Earnings Growth & Price Strength Make Axon Enterprise (AXON) a Stock to Watch (Zacks)
Dec-05-24 03:33PM	Jim Cramer Calls Axon Enterprise, Inc. (AXON) A Definitive Trump Stock (Insider Monkey)
08:43AM	Morgan Stanley Upgrades Axon Enterprise, Inc. (AXON) to Overweight, Highlights AI Growth and $700 Price Target (Insider Monkey)
Dec-03-24 04:37PM	S&P 500 Gains and Losses Today: Palantir Soars as Government Okays Cloud Products (Investopedia) +5.26%
10:49AM	Axon up as Morgan Stanley bullish on taser maker's strong growth (Investing.com)
08:00AM	Loomis US Deploying Axon Body Cameras to Enhance Safety (PR Newswire)
Nov-29-24 02:47PM	Axon Enterprise CEO on growth, the incoming administration, and AI capabilities (CNBC TV)
03:44AM	Is Axon Enterprise (AXON) The Best Prison and Law Enforcement Stock To Invest In? (Insider Monkey)
Nov-28-24 09:00AM	Investors Heavily Search Axon Enterprise, Inc (AXON): Here is What You Need to Know (Zacks)
Nov-22-24 10:08AM	What Contributes To Axon Enterprises (AXON) Robust Growth? (Insider Monkey)
06:13AM	Goldman Sachs: Axon Enterprise (AXON) Is A Top Growth Investor Stock (Insider Monkey)
Nov-20-24 06:18AM	Palantir, The Newest S&P 500 Stock, Is Leaving Nvidia In The Dust. But It's Not No. 1. (Investor's Business Daily)
01:30AM	This Stock Could Gain From the Coming Crackdown on Crime (Barrons.com)
Nov-14-24 04:01PM	Axon is Awarded a Federal Government Contract to Supply the Royal Canadian Mounted Police (RCMP) with Body-Worn Cameras (PR Newswire)
01:38PM	Crypto Play Leads 6 Newer IPOs Lead 21 'Perfect' Stocks (Investor's Business Daily)
12:27PM	Coinbase And 5 Other Newer IPOs Lead 21 'Perfect' Stocks (Investor's Business Daily)
09:30AM	Axon (AXON) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
09:00AM	Here is What to Know Beyond Why Axon Enterprise, Inc (AXON) is a Trending Stock (Zacks)
Nov-09-24 12:05AM	Decoding Axon Enterprise Inc (AXON): A Strategic SWOT Insight (GuruFocus.com)
Nov-08-24 04:39PM	S&P 500 Gains and Losses Today: Axon Shares Surge as Taser Maker Tops Estimates (Investopedia) +28.68%
04:15PM	Taser Maker Axon Soars On Uplifting Guidance After Trump Election (Investor's Business Daily)
02:40PM	Axon, Taser Maker And Trump Stock, Soars On Uplifting Guidance (Investor's Business Daily)
02:34PM	Axon's Stock Explodes 29% After Game-Changing Q3 Earnings and Bold AI Vision (GuruFocus.com)
01:40PM	Top Stock Movers Now: Axon Enterprise, Sweetgreen, Akamai Technologies, and More (Investopedia)
01:29PM	Axon Enterprise Stock Pops 25% After It Posts Upbeat Results and Outlook (Investopedia)
12:08PM	This Taser Makers Stock Is Todays Best S&P 500 Performer. Heres Why. (Barrons.com)
12:07PM	Why Axon Enterprise Stock Soared to an All-Time High Today (Motley Fool)
09:40AM	Are Industrial Products Stocks Lagging Axon Enterprise (AXON) This Year? (Zacks)
07:27AM	Axon Stock Soars On Uplifting Guidance After Earnings Beat (Investor's Business Daily)
02:31AM	Axon Enterprise Inc (AXON) Q3 2024 Earnings Call Highlights: Record Growth and Strategic ... (GuruFocus.com)
Nov-07-24 06:00PM	Axon (AXON) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:15PM	Axon Enterprise (AXON) Tops Q3 Earnings and Revenue Estimates (Zacks)
04:13PM	Axon (NASDAQ:AXON) Reports Strong Q3, Stock Jumps 11.1% (StockStory)
04:08PM	Axon: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Axon reports Q3 2024 revenue of $544 million, up 32% year over year, raises outlook (PR Newswire)
09:11AM	Axon Enterprise (AXON) Recorded Over 25% Revenue Growth for the 10th Consecutive Quarter (Insider Monkey)
Nov-05-24 10:00AM	Axon Earnings Preview (GuruFocus.com)
Nov-01-24 05:50PM	Axon Enterprise (AXON) Rises Higher Than Market: Key Facts (Zacks)
04:00AM	2 Potential Stock-Split AI Stocks Up 212% and 730% in 5 Years to Buy Now, According to Wall Street (Motley Fool)
Oct-30-24 09:00AM	Is Trending Stock Axon Enterprise, Inc (AXON) a Buy Now? (Zacks)
Oct-28-24 06:00PM	Axon Enterprise (AXON) Gains But Lags Market: What You Should Know (Zacks)
Oct-25-24 09:30AM	Wall Street Analysts See Axon (AXON) as a Buy: Should You Invest? (Zacks)
Oct-24-24 04:01PM	Axon to Release Third Quarter 2024 Earnings on November 7, 2024 (PR Newswire)
Oct-22-24 12:34PM	Axon Enterprise (AXON) Surged on Robust Demand (Insider Monkey)
Oct-18-24 03:42PM	Campbell Police Department Secures Groundbreaking Waiver for 24/7 Drone as First Responder (DFR) Operations (PR Newswire)
Oct-17-24 08:39AM	Is Axon Enterprise, Inc. (AXON) the Most Profitable Industrial Stock to Invest In? (Insider Monkey)
Oct-16-24 09:00AM	Axon Enterprise, Inc (AXON) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Oct-13-24 03:18PM	Is Axon Enterprise Inc. (AXON) the Most Profitable NASDAQ Stock to Invest In? (Insider Monkey)
Oct-07-24 06:00PM	Axon Enterprise (AXON) Stock Moves -0.23%: What You Should Know (Zacks)
Oct-03-24 03:49PM	Jim Cramer Says Axon Enterprise, Inc. (AXON) Has Been Red Hot For Ages (Insider Monkey)
08:38AM	Axon Enterprise, Inc. (AXON): A Good Breakout Stock to Invest In Right Now (Insider Monkey)

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kalinowski Caitlin Elizabeth	Director	Jan 02 '25	Sale	604.07	450	271,832	6,929	Jan 02 05:52 PM
CAITLIN KALINOWSKI	Director	Jan 02 '25	Proposed Sale	594.32	450	267,444		Jan 02 04:28 PM
Kunins Jeffrey C	CPO & CTO	Dec 23 '24	Sale	624.47	1,035	646,329	124,243	Dec 26 04:20 PM
JEFFREY C KUNINS	Officer	Dec 23 '24	Proposed Sale	631.69	1,035	653,799		Dec 23 04:22 PM
Isner Joshua	PRESIDENT	Dec 17 '24	Sale	642.43	1,291	829,375	181,892	Dec 17 06:52 PM
Kunins Jeffrey C	CPO & CTO	Dec 17 '24	Sale	639.14	1,370	875,623	125,950	Dec 17 06:50 PM
JEFFREY C KUNINS	Officer	Dec 17 '24	Proposed Sale	649.30	1,370	889,541		Dec 17 04:28 PM
Isner Joshua	Officer	Dec 17 '24	Proposed Sale	642.43	1,291	829,375		Dec 17 12:35 PM
GARNREITER MICHAEL	Director	Dec 16 '24	Sale	639.69	1,000	639,687	24,259	Dec 16 06:07 PM
THE GARNREITER FAMILY TRUST U/	Director	Dec 16 '24	Proposed Sale	644.91	1,000	644,910		Dec 16 04:32 PM
Cullivan Julie A	Director	Dec 04 '24	Sale	682.06	1,261	860,077	2,392	Dec 05 05:09 PM
Kunins Jeffrey C	CPO & CTO	Dec 03 '24	Sale	654.79	2,304	1,508,628	128,542	Dec 04 05:19 PM
Kunins Jeffrey C	CPO & CTO	Dec 04 '24	Sale	667.09	333	222,141	128,209	Dec 04 05:19 PM
Cullivan Julie A	Director	Dec 04 '24	Proposed Sale	682.06	1,261	860,077		Dec 04 04:51 PM
Isner Joshua	PRESIDENT	Dec 03 '24	Sale	647.38	2,258	1,461,782	184,987	Dec 04 04:48 PM
Isner Joshua	PRESIDENT	Dec 04 '24	Sale	667.09	836	557,687	184,151	Dec 04 04:48 PM
JEFFREY C KUNINS	Officer	Dec 04 '24	Proposed Sale	669.87	333	223,067		Dec 04 04:37 PM
Isner Joshua	Officer	Dec 04 '24	Proposed Sale	667.09	836	557,687		Dec 04 11:38 AM
JEFFREY C KUNINS	Officer	Dec 03 '24	Proposed Sale	636.39	2,304	1,466,243		Dec 03 04:32 PM
Isner Joshua	Officer	Dec 03 '24	Proposed Sale	647.38	2,258	1,461,782		Dec 03 12:39 PM
Bagley Brittany	COO & CFO	Nov 22 '24	Sale	640.00	3,500	2,240,000	76,635	Nov 25 04:55 PM
Isner Joshua	PRESIDENT	Nov 21 '24	Sale	635.06	9,600	6,096,539	189,567	Nov 25 04:47 PM
BRITTANY BAGLEY	Officer	Nov 22 '24	Proposed Sale	640.00	3,500	2,240,000		Nov 22 04:24 PM
Isner Joshua	Officer	Nov 21 '24	Proposed Sale	635.06	9,600	6,096,539		Nov 21 01:49 PM
MCBRADY MATTHEW R	Director	Nov 20 '24	Sale	605.20	1,000	605,196	3,892	Nov 20 04:29 PM
Matthew McBrady	Director	Nov 20 '24	Proposed Sale	610.35	1,000	610,350		Nov 20 12:38 PM
Bagley Brittany	COO & CFO	Nov 15 '24	Sale	598.75	6,325	3,787,070	80,135	Nov 19 04:35 PM
GARNREITER MICHAEL	Director	Nov 15 '24	Sale	599.53	1,000	599,530	25,259	Nov 19 04:33 PM
BRITTANY BAGLEY	Officer	Nov 15 '24	Proposed Sale	604.56	6,325	3,823,842		Nov 15 04:40 PM
Kunins Jeffrey C	CPO & CTO	Nov 13 '24	Sale	609.27	21,834	13,302,895	132,560	Nov 14 04:55 PM
Kunins Jeffrey C	CPO & CTO	Nov 12 '24	Sale	593.88	21,834	12,966,791	154,394	Nov 14 04:55 PM
Isner Joshua	PRESIDENT	Nov 12 '24	Sale	606.15	20,000	12,123,060	208,166	Nov 13 04:57 PM
JEFFREY C KUNINS	Officer	Nov 13 '24	Proposed Sale	609.27	21,834	13,302,895		Nov 13 04:22 PM
JEFFREY C KUNINS	Officer	Nov 12 '24	Proposed Sale	593.88	21,834	12,966,791		Nov 12 04:32 PM
Isner Joshua	Officer	Nov 12 '24	Proposed Sale	606.11	20,000	12,122,117		Nov 12 11:09 AM
GARNREITER MICHAEL	Director	Oct 15 '24	Sale	437.98	1,000	437,980	26,259	Oct 16 04:23 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Oct 03 '24	Sale	404.14	4,767	1,926,545	2,925,060	Oct 04 04:26 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Oct 01 '24	Option Exercise	399.22	100,917	40,288,085	3,031,116	Oct 02 08:27 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Oct 02 '24	Option Exercise	404.51	58,965	23,851,932	3,042,767	Oct 02 08:27 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Sep 30 '24	Option Exercise	399.60	10,118	4,043,153	2,935	Oct 02 08:27 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Oct 02 '24	Sale	402.99	112,940	45,513,920	2,929,827	Oct 02 08:27 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Oct 01 '24	Sale	400.07	47,314	18,928,997	2,983,802	Oct 02 08:27 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Sep 30 '24	Sale	400.02	4,746	1,898,515	2,930,199	Oct 02 08:27 PM
PATRICK SMITH	Director	Oct 02 '24	Proposed Sale	399.22	117,707	46,990,989		Oct 02 06:53 PM
Williams Jeri	Director	Sep 30 '24	Sale	400.00	110	44,000	1,934	Oct 01 05:02 PM
PATRICK SMITH	Director	Oct 01 '24	Proposed Sale	399.60	47,314	18,906,674		Oct 01 04:37 PM
PATRICK SMITH	Director	Sep 30 '24	Proposed Sale	395.34	4,746	1,876,284		Sep 30 04:28 PM
JERI L WILLIAMS	Director	Sep 30 '24	Proposed Sale	395.34	110	43,487		Sep 30 04:27 PM
GARNREITER MICHAEL	Director	Sep 16 '24	Sale	380.99	1,000	380,990	27,259	Sep 17 04:58 PM
Bagley Brittany	COO & CFO	Sep 12 '24	Sale	378.95	4,338	1,643,876	98,825	Sep 12 05:15 PM
BRITTANY BAGLEY	Officer	Sep 12 '24	Proposed Sale	378.95	4,338	1,643,876		Sep 12 04:04 PM
Isner Joshua	PRESIDENT	Sep 10 '24	Sale	359.84	25,811	9,287,936	228,166	Sep 10 07:24 PM
Kunins Jeffrey C	CPO & CTO	Sep 09 '24	Sale	364.86	8,182	2,985,294	176,228	Sep 10 06:01 PM
Isner Joshua	Officer	Sep 10 '24	Proposed Sale	360.55	5,874	2,117,897		Sep 10 05:13 PM
Isner Joshua	Officer	Sep 10 '24	Proposed Sale	359.63	19,937	7,170,039		Sep 10 04:57 PM
JEFFREY C KUNINS	Officer	Sep 09 '24	Proposed Sale	354.62	8,182	2,901,501		Sep 09 04:32 PM
Cullivan Julie A	Director	Sep 05 '24	Sale	353.53	900	318,177	3,653	Sep 06 04:38 PM
JULIE ANNE CULLIVAN	Director	Sep 05 '24	Proposed Sale	355.35	900	319,815		Sep 05 04:27 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Aug 30 '24	Option Exercise	364.97	105,495	38,502,510	3,030,861	Sep 04 05:51 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Sep 03 '24	Option Exercise	355.16	64,505	22,909,596	3,045,366	Sep 04 05:51 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Sep 03 '24	Sale	356.53	75,000	26,739,978	2,970,366	Sep 04 05:51 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Aug 30 '24	Sale	364.02	50,000	18,201,051	2,980,861	Sep 04 05:51 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Sep 04 '24	Sale	352.57	45,539	16,055,756	2,924,827	Sep 04 05:51 PM
PATRICK W SMITH	Director	Sep 04 '24	Proposed Sale	355.16	2,539	901,751		Sep 04 04:19 PM
PATRICK W SMITH	Director	Aug 30 '24	Proposed Sale	362.00	168,000	60,816,000		Aug 30 04:36 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Aug 23 '24	Option Exercise	370.70	170,000	63,019,000	3,095,666	Aug 27 05:26 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Aug 23 '24	Sale	371.78	80,300	29,854,273	3,015,366	Aug 27 05:26 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Aug 26 '24	Sale	362.21	70,000	25,354,817	2,945,366	Aug 27 05:26 PM
SMITH PATRICK W	CHIEF EXECUTIVE OFFICER	Aug 27 '24	Sale	362.21	20,000	7,244,146	2,925,366	Aug 27 05:26 PM
Williams Jeri	Director	Aug 22 '24	Sale	375.94	220	82,707	2,044	Aug 23 04:30 PM
PATRICK W SMITH	Director	Aug 23 '24	Proposed Sale	372.69	170,300	63,469,107		Aug 23 04:28 PM
Kalinowski Caitlin Elizabeth	Director	Aug 21 '24	Sale	373.03	450	167,864	7,379	Aug 22 04:38 PM
JERI L WILLIAMS	Director	Aug 22 '24	Proposed Sale	375.10	220	82,522		Aug 22 04:24 PM
CAITLIN KALINOWSKI	Director	Aug 21 '24	Proposed Sale	373.03	450	167,864		Aug 21 04:07 PM
GARNREITER MICHAEL	Director	Aug 16 '24	Sale	374.99	1,000	374,990	29,259	Aug 19 04:40 PM
Bagley Brittany	COO & CFO	Aug 15 '24	Sale	374.32	2,017	755,005	108,205	Aug 16 04:41 PM
THE GARNREITER FAMILY TRUSTU/A	Director	Aug 16 '24	Proposed Sale	373.69	4,000	1,494,760		Aug 16 04:26 PM
BRITTANY BAGLEY	Officer	Aug 15 '24	Proposed Sale	370.57	2,017	747,440		Aug 15 04:31 PM
MCBRADY MATTHEW R	Director	Aug 09 '24	Sale	364.66	2,000	729,328	4,892	Aug 12 04:26 PM
Matthew Mcbrady	Director	Aug 09 '24	Proposed Sale	365.00	2,000	730,000		Aug 09 03:28 PM
Isner Joshua	PRESIDENT	Jun 18 '24	Sale	297.78	1,434	427,016	273,332	Jun 20 04:42 PM
Cullivan Julie A	Director	May 31 '24	Sale	281.72	993	279,748	4,553	Jun 03 07:23 PM
Cullivan Julie A	Director	May 28 '24	Sale	286.04	478	136,727	5,546	May 29 04:37 PM
Kalinowski Caitlin Elizabeth	Director	May 20 '24	Sale	290.19	2,000	580,387	7,829	May 21 04:20 PM
Williams Jeri	Director	May 09 '24	Sale	310.07	308	95,501	1,607	May 13 05:51 PM
Kunins Jeffrey C	CPO & CTO	May 09 '24	Sale	309.94	43,668	13,534,282	189,719	May 13 05:48 PM
Isner Joshua	PRESIDENT	May 09 '24	Sale	309.96	44,000	13,638,357	275,843	May 13 05:45 PM

OCX

Oncocyte Corporation

AXON

Axon Enterprise Inc

Upgrade your FINVIZ experience